Senior Vice President, Novel TechnologiesJoseph Rabinowitz is the Senior Vice President of Novel Technologies at Kriya. Joseph joined Kriya from Pfizer where he was the Senior Director of Capsid Development in the Rare Disease Research Unit leading a team generating AAV viral libraries. Joseph brings over 20 years of experience in AAV vector development. Prior to working at Pfizer, he was a faculty member at Temple University and Thomas Jefferson University. Joseph received his PhD in genetics from Case Western Reserve University and completed his postdoctoral work in Gene Therapy at University of North Carolina at Chapel Hill. Joseph received his undergraduate degree in microbiology from the University of Arizona, Tucson.